Likewise, in another clinical trial, formula supplemented with IgA/IgG (73%/26%) failed to reduce NEC incidence and severity in human neonates [222], and oral gentamicin was found to be more effective at preventing NEC compared to oral IgA/IgG administration alone [223]. This evidence concerns the gene CD79A and necrotizing enterocolitis.